Celularity Inc. Class A Common Stock

CELUNASDAQ • USD
ThemeHealthcare - Oncology›Cell & Gene Therapy for Cancer
0.87 USD
↘ 0.12 (12.33%)AT CLOSE (11:59 AM EDT)
0.86
↘ 0.01 (1.07%)
POST MARKET (AS OF 07:52 PM EDT)
Post Market
AS OF 07:52 PM EDT
0.86
↘ 0.01 (1.07%)
🔴Market: CLOSED
Open?$1.02
High?$1.02
Low?$0.85
Prev. Close?$1.00
Volume?34.3K
Avg. Volume?181.7K
VWAP?$0.93
Rel. Volume?0.19x
Bid / Ask
Bid?$0.85 × 11.7K
Ask?$0.88 × 500
Spread?$0.03
Midpoint?$0.86
Valuation & Ratios
Market Cap?25.2M
Shares Out?28.9M
Float?7.3M
Float %?25.1%
P/E Ratio?N/A
P/B Ratio?-0.66
EPS?-$3.17
Dividend?0.00%
Ex-Dividend?N/A

CELU is currently priced at $0.87. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Strong Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (241.3%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, CELU appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
Themes
Healthcare - Oncology›Cell & Gene Therapy for CancerBiotech - Drug Development›Clinical-Stage Platforms
Employees
115
Market Cap
25.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.celularity.com
Listed
2021-07-19
Address
170 PARK AVE
FLORHAM PARK, NJ 07932
Phone: (908) 768-2170
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookStrong Sell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
10
Short Sent.?
71
Piotroski F-Score?0/9Weak
Altman Z-Score?-15.23Distress
Confidence?50%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?5.13%Elevated
Short Interest?373.2K
Days to Cover?1.3
Free Float7.3M
Avg Daily Volume281.4K
Settlement Date2026-05-15
Financial Health
Current Ratio?0.15Weak
Quick Ratio?0.15Weak
Cash Ratio?0.08Low
Debt/Equity?-1.26Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
S&P
97
-0.66CHEAP▾
P/S?
Peers
100
S&P
87
0.95CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.2CHEAP▾
EV/Sales?
Peers
100
S&P
67
2.52CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
241.3%STRONG▾
ROA?
S&P
3
-85.6%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$66.8M
Fundamentals ratios updated end of day
MarketsMoversWatchlist